Gyon Technologies Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,570
Closed -$631K 129
2022
Q4
$631K Sell
5,570
-8,219
-60% -$902K 0.24% 131
2022
Q3
$1.11M Buy
13,789
+968
+8% +$82K 0.35% 86
2022
Q2
$956K Buy
+12,821
New +$1.17M 0.27% 115
2022
Q1
Sell
-7,760
Closed -$1.04M 349
2021
Q4
$1.04M Sell
7,760
-11,492
-60% -$1.65M 0.19% 149
2021
Q3
$2.63M Buy
19,252
+5,280
+38% +$666K 0.71% 36
2021
Q2
$1.49M Buy
13,972
+7,684
+122% +$738K 0.49% 72
2021
Q1
$565K Sell
6,288
-11,264
-64% -$1.06M 0.25% 128
2020
Q4
$1.62M Buy
+17,552
New +$1.57M 0.56% 42

Other funds holding DXCM

Gyon Technologies Capital Management's DXCM Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of DexCom (DXCM) in Q1 2023, closing a stake of 5,570 shares — an estimated $631K sold.

Gyon Technologies Capital Management first reported a position in DXCM in Q4 2020 and held it in 8 quarters. The position peaked at $2.63M in Q3 2021. 905 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 5,570 DexCom shares in Q1 2023, an estimated $631K.
  • Gyon Technologies Capital Management first reported a position in DexCom in Q4 2020 and held it in 8 quarters.
  • Gyon Technologies Capital Management's DexCom position peaked at $2.63M in Q3 2021.
  • 905 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.